Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible
medical robotics and the developer of robotic technology for
accurate 3D control of catheter movement, will showcase its Sensei®
X Robotic Catheter System and the Artisan Extend(TM) Control
Catheter at the 15th Annual Boston Atrial Fibrillation Symposium,
Jan. 14-16, 2010 (Booth 210). In addition, the company will
highlight its Lynx(TM) Robotic Ablation Catheter, a small, flexible
irrigated ablation catheter that will be available to customers in
Europe following CE Mark approval.
"We are very encouraged by the positive response to our new
flexible robotics platform in such a short period of time following
its launch in September 2009," said Frederic Moll, M.D., president
and CEO, Hansen Medical. "Hansen Medical remains steadfast in its
commitment to developing innovative technological solutions that
address the clinical needs of electrophysiologists by extending the
procedural capabilities of robotic catheter control during EP
procedures."
The Sensei X system is the next generation flexible robotic
platform that integrates advanced levels of 3D catheter control
with 3D visualization, providing enhanced accuracy and stability to
physicians during complex cardiac arrhythmia procedures. The Sensei
X platform supports the Artisan Extend control catheter, which
increases the reachability and navigation properties of the Artisan
catheter by offering more than 20 percent improvement in both bend
and reach. As a result, physicians have the ability to place
catheters deliberately and accurately within the heart. In
addition, the Artisan Extend catheter offers improvements in setup
and workflow, and is designed to improve usability and reduce
procedure time.
"The new robotic platform enables us to navigate and control the
catheter in 3D with greater stability and enhanced responsiveness,
which improves our ability to perform successful complex arrhythmia
mapping procedures safely," said Rahul N. Doshi, Director,
Arrhythmia Services and Chair, Cardiothoracic, St. Jude Medical
Center, Fullerton, Calif. "In addition, we are experiencing a
reduction in fluoroscopy time and radiation dosage during flexible
robotic procedures.
"During our initial evaluation of the Artisan Extend catheter,
we found that the improved flexibility and bend radius allowed
access to anatomic targets that are typically hard to reach when
using manual technique. In addition, setup for the Artisan Extend
was simplified, so our procedure time was reduced," continued Dr.
Doshi.
The Sensei X platform also supports Hansen Medical's
CoHesion(TM) 3D Visualization Module, which integrates the 3D
motion control of the Sensei X system with the 3D visualization of
the St. Jude Medical EnSite(TM) system. Two features of the Sensei
X system designed to improve procedural planning and workflow
include Workspace Visualization, an enhancement that allows
physicians to see the catheter's reach on a 3D map prior to
navigation, and EndoView, a feature that allows physicians to
quickly change the orientation to a standard endoscopic view.
The Lynx robotic ablation catheter will also be supported by the
Sensei X platform and will leverage the navigation capability of
the Artisan Extend catheter, but in a smaller and more flexible
integrated profile for the treatment of Atrial Fibrillation (AF)
and other electrophysiology disorders. The Lynx catheter is pending
CE Mark approval and is expected to be available in the European
Union in the first half of 2010.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, Calif., develops
products and technology using robotics for the accurate
positioning, manipulation, and control of catheters and
catheter-based technologies. Its first product, the Sensei® Robotic
Catheter system, is a robotic navigation system that enables
clinicians to place mapping catheters in hard-to-reach anatomical
locations within the heart easily, accurately and with stability
during complex cardiac arrhythmia procedures. The Sensei system is
compatible with fluoroscopy, ultrasound, 3D surface map and patient
electrocardiogram data and was cleared by the U.S. Food and Drug
Administration (FDA) in May 2007 for manipulation and control of
certain mapping catheters in Electrophysiology (EP) procedures. The
safety and effectiveness of the Sensei system for use with cardiac
ablation catheters in the treatment of cardiac arrhythmias,
including atrial fibrillation (AF), have not been established. In
the European Union, the Sensei system is cleared for use during EP
procedures, such as guiding catheters in the treatment of AF.
Additional information can be found at www.hansenmedical.com.
Forward-Looking Statements
This press release contains forward-looking statements that
involve risks, uncertainties, assumptions, and other factors,
which, if they do not materialize or prove correct, could cause
Hansen's results to differ materially from those expressed or
implied, by such forward-looking statements. All statements, other
than statements of historical fact, are statements that could be
deemed forward-looking statements, including, statements containing
the words "plan," "expects," "believes," "goal," "estimate," "may"
and similar words. Hansen intends such forward-looking statements
to be covered by the safe harbor provisions for forward-looking
statements contained in Section 21E of the Exchange Act and the
Private Securities Litigation Reform Act of 1995. Important factors
that could cause actual results to differ materially from those
indicated by such forward-looking statements include, among others,
product development risks, potential safety and regulatory issues
that could delay approvals, and the scope and validity of
intellectual property rights applicable to products being
developed. These and other risks are described in greater detail
under the heading "Risk Factors" contained in our periodic SEC
filings, including our Quarterly Report on Form 10-Q filed with the
SEC on November 16, 2009. Given these uncertainties, you should not
place undue reliance on the forward-looking statements in this
press release. We undertake no obligation to revise or update
information herein to reflect events or circumstances in the
future, even if new information becomes available.
Hansen Medical, Heart Design, Hansen Medical & Heart Design,
Sensei and IntelliSense are registered trademarks, and Artisan,
Artisan Extend, Lynx, CoHesion, Fine Force Technology and
Instinctive Motion are trademarks of Hansen Medical Inc., in the
United States and other countries.
EnSite is a trademark of St. Jude Medical.
Image Available:
http://www2.marketwire.com/mw/frame_mw?attachid=1152683
News Media Contact: Amy Cook 925.552.7893 Email Contact Investor
Contacts: Steven Van Dick 650.404.5800 Email Contact Lasse Glassen
Financial Relations Board 213.486.6546 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024